REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Access Private Limited (India)

Main Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Pharma Access Private Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

pharma access is a pharmaceutical engineering company that provides turnkey solutions for the production of generic product forms such as Tablets, Capsules, Liquid Oral Syrups, Ointments, and creams. With over two decades of experience, they specialize in pharmaceutical projects with a centralized BPF approach. Their integrated facilities prioritize quality and time efficiency.

Legal Address
702, Supreme Chambers, Shah Industrial Estate, Near Veera Desai, Andheri West,
Mumbai; Maharashtra; Postal Code: 400053

Contact Details: Purchase the Pharma Access Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Access Private Limited report to view the information.
Registered Capital:
Purchase the Pharma Access Private Limited report to view the information.
Financial Auditors:
Purchase the Pharma Access Private Limited report to view the information.
Incorporation Date:
August 13, 2013
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Pharma Access Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
34.19%
Total operating revenue
31.29%
Operating Profit/Loss (EBIT)
-15.03%
EBITDA
-14.21%
Net Profit/Loss for the Period
-18.04%
Total Assets
14.66%
Total Equity
27.31%
Operating Profit Margin (ROS)
-9.23%
Net Profit Margin
-7%
Return on Equity (ROE)
-11.87%
Debt/Equity
2.09%
Quick Ratio
0.36%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?